Trexquant Investment LP Spring Works Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $323,311 - $440,879	12,948 Added 35.09%	49,843 $1.28 Million
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $140,810 - $186,105	-6,480 Reduced 14.94%	36,895 $959,000
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $1.08 Million - $1.78 Million	-44,972 Reduced 50.9%	43,375 $1.24 Million
Q2 2022 Aug 11, 2022	BUY	$18.36 - $60.07 $1.62 Million - $5.31 Million	88,347 New	88,347 $2.18 Million
Q4 2020 Feb 11, 2021	SELL	$48.36 - $77.92 $351,770 - $566,790	-7,274 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$36.14 - $51.99 $262,882 - $378,175	7,274 New	7,274 $347,000

239

70.8M

151K

255K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.58B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.